马匹医疗保健市场规模、份额和成长分析（按产品类型、疾病类型、分销管道、最终用户和地区）- 产业预测 2025-2032

马匹医疗保健市场规模预计到 2023 年将达到 37.9 亿美元，并从 2024 年的 40.6 亿美元增长到 2032 年的 69.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.0%。

由于研发倡议加大、马匹健康併发症增加以及马匹治疗方法的接受度不断提高，马匹医疗保健市场正在经历强劲增长。人工智慧（AI）的引入对该领域产生了重大影响，激发了致力于将该技术融入马科动物实践的兽医研究人员的创新。主要企业正在积极支持这些进步，以应对持续存在的挑战，并透过及时的健康评估加强医疗管理。这项技术的进步正在提高马匹的早期疾病诊断和个人化治疗。马匹健康照护包括预防性照护、疾病管理、跛足治疗、生殖照护和解决行为问题，最终改善马匹的整体健康状况、早期发现疾病并延长马匹的寿命。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

马匹医疗保健市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概况
• 药物
• 疫苗
• 药物饲料添加剂

马匹医疗保健市场规模（按疾病类型和复合年增长率） (2025-2032)

• 市场概况
• 马流感
• 马疱疹病毒
• 马脑脊髓炎
• 马西尼罗河病毒
• 其他的

马匹医疗保健市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 兽医诊所
• 兽医诊所
• 零售药局
• 网路药局

马匹医疗保健市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 兽医诊所
• 兽医诊所
• 其他的

马匹医疗保健市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Elanco Animal Health（USA）
• Bayer AG（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Dechra Pharmaceuticals PLC（UK）
• IDEXX Laboratories, Inc.（USA）
• Vetoquinol SA（France）
• Norbrook Laboratories Limited（UK）
• EQUINE PRODUCTS UK LTD（UK）
• KRKA（Slovenia）
• HIPRA（Spain）
• Luitpold Pharmaceuticals, Inc.（USA）
• Affymetrix Inc.（USA）
• Sanofi（France）
• Novartis Animal Health（Switzerland）
• Signostics（Australia）
• Merial（USA）

结论和建议

Equine Healthcare Market size was valued at USD 3.79 billion in 2023 and is poised to grow from USD 4.06 billion in 2024 to USD 6.97 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The equine healthcare market is experiencing robust growth, driven by a surge in research and development initiatives, a rise in equine health complications, and the increasing acceptance of equine-based therapies. The introduction of artificial intelligence (AI) is significantly impacting the sector, fostering innovation among veterinary researchers focused on integrating this technology into equine practices. Leading companies are actively supporting these advancements to tackle persistent challenges and enhance healthcare management through timely health assessments. This technological evolution is enhancing early disease diagnosis and personalized treatments for horses. Equine healthcare encompasses preventive care, illness management, lameness treatment, reproductive care, and addressing behavioral issues, ultimately promoting better overall health, early disease detection, and longevity for equine companions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Equine Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Equine Healthcare Market Segments Analysis

Global Equine Healthcare Market is segmented by Product Type, Disease Type, Distribution Channel, End User and region. Based on Product Type, the market is segmented into Drugs, Vaccines and Medical Feed Additives. Based on Disease Type, the market is segmented into Equine Influenza, Equine Herpesvirus, Equine Encephalomyelitis, Equine West Nile Virus and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies and Online Pharmacies. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Equine Healthcare Market

The Equine Healthcare market is experiencing robust growth, fueled by the surging popularity of equine sports and recreational activities. Events such as horse racing, show jumping, and dressage necessitate the maintenance of healthy and well-cared-for horses, thereby driving demand for healthcare products and services. This heightened enthusiasm for equine activities has led to increased investments in vaccinations, nutritional supplements, and grooming essentials, all aimed at promoting the overall well-being of horses. As more individuals engage in these activities, the need for comprehensive equine healthcare solutions expands, highlighting the market's potential for continued development and innovation.

Restraints in the Equine Healthcare Market

The Equine Healthcare market is significantly hindered by the high costs associated with equine medical products and services. Veterinary care for horses, including surgeries, specialized therapies, and routine check-ups, can be prohibitively expensive for small facilities. Although advanced diagnostic tools and treatments may offer effective solutions, their financial implications can pose serious challenges. This financial burden is particularly pronounced in emerging economies where disposable incomes are limited, further restricting the market's growth potential. As a result, the steep costs of necessary equine healthcare services deter investment and accessibility, ultimately impacting the overall development of the industry.

Market Trends of the Equine Healthcare Market

The incorporation of telemedicine in equine healthcare is emerging as a significant market trend, revolutionizing how veterinary services are delivered to horse owners. As digital platforms gain traction, veterinarians can now conduct consultations, monitor recovery, and provide expert guidance remotely, enhancing accessibility for horse owners, especially in rural or remote areas where advanced care may be scarce. This shift not only improves the convenience and efficiency of veterinary services but also reduces the costs associated with transporting horses for routine check-ups and minor treatments. As a result, telemedicine is expected to play a pivotal role in shaping the future of equine healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Equine Healthcare Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Drugs
• Vaccines
• Medical Feed Additives

Global Equine Healthcare Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Equine Influenza
• Equine Herpesvirus
• Equine Encephalomyelitis
• Equine West Nile Virus
• Others

Global Equine Healthcare Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies
• Online Pharmacies

Global Equine Healthcare Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Others

Global Equine Healthcare Market Size & CAGR (2025-2032)

• North America (Product Type, Disease Type, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Disease Type, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Type, Distribution Channel, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EQUINE PRODUCTS UK LTD (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KRKA (Slovenia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luitpold Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Animal Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signostics (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merial (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations